The pharmacokinetic behaviour of doramectin after a single subcutaneous administration and moxidectin following a single subcutaneous or oral drench were studied in goats at a dosage of 0.2 mg kg–1. The drug plasma concentration-time data were analysed by compartmental pharmacokinetics and non-compartmental methods. Maximum plasma concentrations of moxidectin were attained earlier and to a greater extent than doramectin (shorter tmaxand greater Cmaxand AUC than doramectin). MRT of doramectin (4.91 ± 0.07 days) was also significantly shorter than that of moxidectin (12.43 ± 1.28 days). Then, the exposure of animals to doramectin in comparison with moxidectin was significantly shorter. The apparent absorption rate of moxidectin was not significantly different after oral and subcutaneous administration but the extent of absorption, reflected in the peak concentration (Cmax) and the area under the concentration-time curve (AUC), of the subcutaneous injection (24.27 ± 1.99 ng ml–1and 136.72 ± 7.35 ng d ml–1respectively) was significantly greater than that of the oral administration (15.53 ± 1.27 ng ml–1and 36.72 ± 4.05 ng d ml–1respectively). The mean residence time (MRT) of moxidectin didn’t differ significantly when administered orally or subcutaneously. Therefore low oral bioavailability and the early emergence of resistance in this minor species may be related. These results deserve to be correlated with efficacy studies for refining dosage requirements of endectocides in this species.